Name
Volasertib
Alternate Names
BI 6727
Abbreviations
None
Category
Chemotherapy
Subcategory
PLK Inhibitor
NSC Number
None
Primary Site
AML trials
Ovarian trials
Solid tumors trials
Histology
None
Remarks
As of 1/1/2013, in multiple clinical trials (both phase I and II) for AML, ovarian tumors and solid tumors. Volasertib is the second in a novel class of drugs call dihydropteridinone derivatives.
Coding
This drug should be coded